Ilyang Pharmaceutical Co.,Ltd

A007570

KR7007570005

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
13,710 ^KRW	+0.22%		-1.01%	-12.40%

2023	Tranche Update on Ilyang Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on April 6, 2023.	CI
2023	Ilyang Pharmaceutical Co.,Ltd's Equity Buyback announced on April 6, 2023, has expired with 115,080 shares, representing 0.63% for KRW 1,999.72 million.	CI

Tranche Update on Ilyang Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on April 6, 2023.

October 10, 2023 at 04:21 am EDT

From July 1, 2023 to October 10, 2023, the company has repurchased 21,080 shares, representing 0.12% for KRW 357 million. With this, the company has completed the repurchase of 115,080 shares, representing 0.64% for KRW 1,999.72 million under the buyback announced on April 6, 2023.

Latest news about Ilyang Pharmaceutical Co.,Ltd

Tranche Update on Ilyang Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on April 6, 2023.	23-10-10	CI
Ilyang Pharmaceutical Co.,Ltd's Equity Buyback announced on April 6, 2023, has expired with 115,080 shares, representing 0.63% for KRW 1,999.72 million.	23-10-09	CI
Tranche Update on Ilyang Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on April 6, 2023.	23-07-13	CI
Ilyang Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Ilyang Pharmaceutical Co.,Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.	23-04-05	CI
Ilyang Pharmaceutical Co.,Ltd authorizes a Buyback Plan.	23-04-05	CI
Tranche Update on Ilyang Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on March 10, 2022.	22-09-08	CI
Ilyang Pharmaceutical Co.,Ltd's Equity Buyback announced on March 10, 2022, has expired with 118,321 shares, representing 0.65% for KRW 2,859.89 million.	22-09-07	CI
Eight South Korean Firms to Donate $2.4 Million Worth of Medicine to Ukraine	22-04-12	MT
Ilyang Pharmaceutical Co.,Ltd announces an Equity Buyback for KRW 3,000 million worth of its shares.	22-03-10	CI
Ilyang Pharmaceutical Co.,Ltd authorizes a Buyback Plan.	22-03-09	CI
Ilyang Pharmaceutical Co.,Ltd(KOSE:A007570) dropped from KOSPI 200 Index	21-12-09	CI
Boryung Pharmaceutical : S.Korea sticks to flu vaccine plan despite safety fears after 25 die	20-10-21	RE
Boryung Pharmaceutical : Number of South Koreans dying after flu shot rises, prompts vaccine worries	20-10-21	RE
Il-Yang Pharmaceutical Signs Licence with Laboratorios Biopas to Export Leukemia Drug Supect to Colombia	16-09-05	CI
Ilyang Pharmaceutical Co., Ltd announced that it has received KRW 30 billion in funding from Hana Daetoo Securities Co., Ltd., Investment Arm, Hanyang Securities Co. Ltd., Investment Arm, Hungkuk Life Insurance Co., Ltd., Korea Securities Finance Corporation, Investment Arm, KTB Investment & Securities Co.,Ltd., and SBI Savings Bank Inc., Investment Arm.	14-06-13	CI
Ilyang Pharmaceutical Co., Ltd announced that it expects to receive KRW 30 billion in funding from Hana Daetoo Securities Co., Ltd., Investment Arm, Hanyang Securities Co. Ltd., Investment Arm, Hungkuk Life Insurance Co., Ltd., Korea Securities Finance Corporation, Investment Arm, KTB Private Equity, and SBI Savings Bank Inc., Investment Arm.	14-06-12	CI
Ilyang Pharmaceutical Co., Ltd's Equity Buyback Plan Extended till September 25, 2022.	12-09-18	CI

Chart Ilyang Pharmaceutical Co.,Ltd

Duration

Period

More charts

Company Profile

Ilyang Pharmaceutical Co Ltd is a Korea-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company mainly manufactures and sells pharmaceutical products including prostatitis agents, anti-inflammatory drugs, diabetic agents, gastritis agents, and others. The Company also produces products including nourishing tonics and health supplements, among others.

Sector

Pharmaceuticals

Calendar

2024-05-13 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
ILYANG PHARMACEUTICAL CO.,LTD	-12.40%	179M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.62%	43.34B
OTSUKA HOLDINGS CO., LTD.	+20.44%	21.96B
SANDOZ GROUP AG	+10.86%	14.09B
CIPLA LIMITED	+13.07%	13.64B
ZYDUS LIFESCIENCES LIMITED	+37.46%	11.43B
ONO PHARMACEUTICAL CO., LTD.	-8.59%	6.86B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+8.46%	5.22B